Sign in
4

Changes in Ownership

Vir Biotechnology, Inc. Filed Acc 0001628280-24-000169

EVP & Chief Medical Officer acquired 80,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Pang Phillip EVP & Chief Medical Officer 2024-01-02 Option exercise +18,833 $0.86 $16,102 206,833 D
Pang Phillip EVP & Chief Medical Officer 2024-01-02 Option exercise +13,576 $1.58 $21,382 220,409 D
Pang Phillip EVP & Chief Medical Officer 2024-01-02 Option exercise +47,591 $1.53 $72,814 268,000 D
Derivatives
Pang Phillip EVP & Chief Medical Officer 2024-01-02 Option exercise · Stock Option (Right to Buy) −18,833 $0.86 $16,102 0 D
Pang Phillip EVP & Chief Medical Officer 2024-01-02 Option exercise · Stock Option (Right to Buy) −13,576 $1.58 $21,382 0 D
Pang Phillip EVP & Chief Medical Officer 2024-01-02 Option exercise · Stock Option (Right to Buy) −47,591 $1.53 $72,814 0 D
Loading xslF345X05/wk-form4_1704311270.xml…